Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does this company has been raising its dividend every year?
$BSEM Biostem Technologies, Inc. (OTC: BSEM) Signs 98-Acre Land Acquisition Contract in Iceland
Source: Marketwired
Biostem Technologies, Inc. (OTC: BSEM) Signs 98-Acre Land Acquisition Contract in Iceland
OAKLAND PARK, FL-(Marketwired - Feb 24, 2016) - Biostem Technologies, Inc. (OTC PINK: BSEM) - Biostem Technologies is pleased to announce executed contract for the purchase of 98 acres of waterfront property for plans to build a rejuvenation spa resort, to include stem cell treatments provided by Biostem Technologies. The property is situated in Reykjavik, Kjalarneshreppur and is approximately a 20-minute drive from the city centre. The signing signifies momentum toward developing "Nesvik" into a forward looking, luxurious and desirable location.
The ISK 145,000,000 (Approx. $1.12 mil USD) purchase agreement from Pera ehf, a company registered in Iceland enables the Biostem Technologies to move ahead with plans to expand into European markets. This expansion is expected to help position Biostem Technologies for continued diversification and economic development opportunities that will benefit the company and shareholders alike.
"The purchase agreement of this parcel of land for future development is a significant step taken in Biostem's commitment to building our international brand and positioning the company and shareholders for future prosperity," Jason Matuszewski, President and Chief Executive Officer, said.
Iceland is known around the world for its natural magnificence, geothermal power, and has become a booming tourism destination. The tourism industry has been growing drastically over recent years in Iceland, "Revenue from foreign tourists amounted to ISK 158,5 billion in 2014, i.e. ISK 27 billion more than in 2013. This represents a year-on-year increase of some 20%," Statistics Iceland.
Biostem Technologies is currently in negotiations with a "green" property development firm out of California for the development of the projected 100+ room facility. The Company believes that as Iceland is one of the fastest growing tourisms destinations in the world, and a central location between the Eastern US and Europe, this location will provide a perfect location to expand Biostem's business model for cellular treatments. We look forward to aiding in the stimulation of Iceland's local and national economy through providing jobs to natives and attracting tourism.
Renovations for the two existing buildings on the property are underway and should be completed by end of Q1.
Statistics Iceland Source:
http://www.ferdamalastofa.is/static/files/ferdamalastofa/Frettamyndir/2015/mai/tourism-in-iceland-in-figures_15.pdf
About Biostem Technologies, Inc. (BSEM):
BioStem Technologies (BSEM) is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. BSEM's goal is to deliver the highest standard wellness and stem cell products that are backed by science. Through scientific studies, we seek to become a world leader in the wellness arena. This will be accomplished by using high quality nutraceuticals and stem cells. Our state of the art laboratory is the first significant step in our quest to introduce the world and our shareholders our dedication to you and your well-being.
Mission Statement- Biostem Technologies is a Global Leader in Anti-Aging research. We are focused on advancing your quality of life, health span and wellness.
Vision Statement- Biostem Technologies is a group of scientists, physicians, and visionaries creating the possibility of living life to its fullest. Our products and strategies are dedicated to helping you live your best, feel your best, and be your best.
Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," believe" or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with OTC Markets.
Contact:
Biostem Technologies, Inc.
Phone: 954-380-8342
Website: http://www.biostemtech.com
Email: info@biostemtech.com
Twitter: @Biostemtech
Facebook: Biostem Technologies
$BSEM Biostem Technologies, Inc. (OTC: BSEM) Announces the Appointment of Dr. Dave Woynarowski as Chief Medical Officer
Source: Marketwired
Biostem Technologies, Inc. (OTC: BSEM) Announces the Appointment of Dr. Dave Woynarowski as Chief Medical Officer
OAKLAND PARK, FL-(Marketwired - Feb 1, 2016) - Dr. Dave Woynarowski was appointed Chief Medical Officer of Biostem Technologies, Inc. (OTC PINK: BSEM) effective immediately. Dr. Woynarowski received his medical degree from Temple University, and served as chief resident in his Internal Medicine Training program. He went on to become part of the resident education system, and twice receiving the prestigious Residents Teaching Award from his students and residents. He holds a Master's Degree in Physiology, and was a Certified Personal Trainer during his early medical career. He also served as Adjunct Professor to Hershey School of Medicine.
Dr. Woynarowski or more simply "Dr. Dave" as he is known to his patients has a background in Internal Medicine, and has been board certified in that discipline. He holds the A4M Anti-Aging medicine certification and was one of the first 30 physicians in the world to attain the AMA's certificate in Age Management Medicine. After practicing Internal Medicine for 15 years and Anti-Aging Medicine for 4 years he founded Dr. Dave's Best Nutraceuticals company in 2002 to fill the void in doctor designed nutraceuticals.
That company was acquired in November 2015 by Biostem Technologies, Inc. and Dr. Dave continues to direct its main functions including research and design.
Dr. Dave is also recognized as a worldwide expert on Telomeres and Telomerase. He has lectured on the topic multiple times to such groups as the A4M and AMMG.
In 2010 he wrote the first text book on Telomere biology for the non-scientist with co authors Dr. Mike Fossel and Greta Blackburn. Currently he is working on a second book which will include his expertise on other age related topics including stem cells and gene therapy.
On his transition to Biostem Technologies, Dr. Dave says, "This is actually a manifestation of a long term dream of mine. I have been working on developing a premier anti-aging team consisting of scientists, researchers, and entrepreneurs who are as dedicated to solving aging as I am. With that team now in place, I am excited to begin pursuing ideas that have been on hold for so long. We look forward to our ideas manifesting themselves into products and services that will help more people sooner!"
About Biostem Technologies, Inc. (BSEM):
Biostem Technologies (BSEM) is engaged in the advancement of regenerative medicine and anti-aging strategies throughout the United States, Europe, and Latin America. BSEM's goal is to deliver the highest standard wellness and stem cell products that are backed by science. Through scientific studies, we seek to become a world leader in the wellness arena. This will be accomplished by using the high quality nutraceuticals and stem cells. Our quest is to introduce the world, and our shareholders to our dedication to you and your well-being.
Mission Statement- Biostem Technologies is a Global Leader in Anti-Aging research. We are focused on advancing your quality of life, health span, and wellness.
Vision Statement- Biostem Technologies is a group of scientists, physicians, and visionaries creating the possibility of living life to its fullest. Our products and strategies are dedicated to helping you live your best, feel your best, and be your best.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," "believe" or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with OTC Markets.
Contact Information
Contact:
Biostem Technologies, Inc.
Phone: 954-380-8342
Website: http://www.biostemtech.com
Email: info@biostemtech.com
Twitter: @biostemtech
Facebook: Biostem Technologies
$BSEM Biostem Technologies Completes Test-O-Shave Product Line Acquisition
Source: InvestorsHub NewsWire
Biostem Technologies Completes Test-O-Shave Product Line Acquisition
Oakland Park, FL -- December 11, 2015 -- InvestorsHub NewsWire -- (OTC: BSEM), Biostem Technologies, Inc. is pleased to announce the acquisition of another product line. Biostem Technologies (BSEM) acquired this asset by virtue of a stock exchange valued at, $155,500. Test-O-Shave is a product line focusing on providing natural grooming and hygiene products. In addition to the mens line of products, Test-O-Shave produces organic soaps, creams, oils, and a womens shave line in development. What sets this product line apart is its natural testosterone boosting ingredients, Pine Pollen and Tribulus.1 It has been shown that bisphenol A (PBA), preservatives and other artificial ingredients can naturally decrease your testosterone levels.1 Therefore; Test-O-Shave, with its all natural Pine Pollen and Tribulus may increase your natural testosterone levels.1 The Company will immediately re-brand this product line to its Bioshave brand to become the foundation of the Company's retail natural grooming and hygiene products.
Dr. Bryan Schuetz D.C., who developed Test-O-Shave stated: Commercially available shave soaps contain chemicals that may cause cancer and reduce normal testosterone levels. After learning of this I decided to form Test-O-Shave, a company that would produce only healthy, chemical free products for men and women to use each day. The first of these products is Test-O-Shave. After using this all natural formula for just a few days you will feel the difference from those old chemical shave creams that are just plain unhealthy for you. Get ready to feel what a real, natural product can do for you.
Jason Matuszewski, CEO of Biostem Technologies, commented: "We have continued to focus on identifying acquisitions as a means to grow and expand our capabilities, product offering and customer base. This last quarter, the company also decided to focus its resources in the upcoming year to penetrate the $5.4 billion cosmeceutical industry.
The acquisition of the Test-O-Shave product line, provides us with a jump-start into this market. It is our goal to complete the re-branding of Test-O-Shave to our Bioshave line and launch our consumer marketing program by the end of the first quarter of 2016.
With a successful product launch following the brand conversion, management anticipates this acquisition will account for an increase in revenues for Biostem Wellness in excess of 30%
For more information about Test-O-Shaves natural grooming and hygiene products please visit www.bioshaveshop.com
1: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
About Biostem Technologies, Inc. (BSEM):
BioStem Technologies (BSEM) is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. BSEM's goal is to deliver the highest standard wellness and stem cell products that are backed by science. Through scientific studies, we seek to become a world leader in the wellness arena. This will be accomplished by using high quality nutraceuticals, cosmeceuticals, and stem cells. Our state of the art laboratory is the first significant step in our quest to introduce the world and our shareholders our dedication to you and your well-being.
Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," believe or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with OTC Markets.
Contact:
Biostem Technologies, Inc.
Phone: 954-380-8342
Website: http://www.biostemtech.com
Email: info@biostemtech.com
Twitter: @Biostemtech
Facebook: https://www.facebook.com/biostemtechnologies/
HOLY MACKEREL !!!!! WOW !!! Glad I'm in this game !!! Keep on going !!!
$$$$$$ loving the news and stock action.
Large spread between bid and ask. Looks like price headed down.
All sales and price is down. I am positive of this stock. I believe positive things are gonna happen and the pps Will reflect.
Is that a good thing or bad thing?
This stock is a needle in a haystack in my opinion. The needle has been found. News released. Things are setting up for a good ride imo.
Check out @biostemtech's Tweet: https://twitter.com/biostemtech/status/666264961656692737?s=09
$BSEM recent news/filings
bullish 8.15
stem cells and telomeres
anti-aging science
http://biostemtechnologies.com
## source: finance.yahoo.com
Sat, 17 Oct 2015 17:04:05 GMT ~ BIOSTEM TECHNOLOGIES INC Financials
read full: http://finance.yahoo.com/q/is?s=bsem
*********************************************************
Thu, 09 Apr 2015 12:51:00 GMT ~ BioStem Technologies Announces the Launch of our New Educational and Interactive Website
[Accesswire] - OAKLAND PARK, FL / ACCESSWIRE / April 9, 2015 / BioStem Technologies, Inc. (OTC PINK: BSEM) announces newly created educational and interactive website set to go live today, April 9, 2015. The launch of ...
read full: http://finance.yahoo.com/news/biostem-technologies-announces-launch-educational-125100482.html
*********************************************************
Thu, 09 Apr 2015 11:00:00 GMT ~ BioStem Technologies Announces the Launch of Our New Educational and Interactive Website
[Marketwired] - BioStem Technologies, Inc. announces newly created educational and interactive website set to go live today, April 9, 2015. The launch of the new website offers simple, fast, and user-friendly access to ...
read full: http://finance.yahoo.com/news/biostem-technologies-announces-launch-educational-110000401.html
*********************************************************
Tue, 27 Jan 2015 12:00:00 GMT ~ Biostem Technologies Announces 1:400 Reverse Stock Split
[Marketwired] - Biostem Technologies, Inc. , today announced that it has completed a 1-for-400 reverse split of its common stock, for all stockholders of record as of January 12th, 2015, effective as of the commencement ...
read full: http://finance.yahoo.com/news/biostem-technologies-announces-1-400-120000254.html
*********************************************************
Thu, 08 Jan 2015 13:00:00 GMT ~ BioStem Technologies (BSEM) Announces Retirement of 128,979,751 Shares of Common Stock and the Issuance of Amended Series B-1
[Accesswire] - Oakland Park, FL / ACCESSWIRE / January 8, 2015 / Biostem Technologies, Inc. (BSEM), announces that it has officially retired 128,979,751 shares of common stock. Furthermore, the company has amended its ...
read full: http://finance.yahoo.com/news/biostem-technologies-bsem-announces-retirement-130000382.html
*********************************************************
$BSEM charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$BSEM company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BSEM/company-info
Ticker: $BSEM
OTC Market Place: OTC Pink Current
CIK code: 0001634730
Company name: BioStem Technologies, Inc.
Company website: http://www.biostemtechnologies.com
Incorporated In: FL, USA
Business Description: BioStem Technologies (BSEM) is engaged in the advancement of regenerative medicine and anti-aging strategies throughout the United States, Europe and Mexico. BSEM's goal is to deliver the highest standard wellness and stem cell products that are backed by science. Through scientific studies, we seek to become a world leader in the wellness arena. This will be accomplished by using high quality nutraceuticals and stem cells. Our state of the art laboratory is the first significant step in our quest to introduce the world and our shareholders our dedication to you and your well-being.Less >>
$BSEM share structure
## source: otcmarkets.com
Market Value: $15,510,640 a/o Nov 13, 2015
Shares Outstanding: 1,903,146 a/o Jun 30, 2015
Float: 409,969 a/o Oct 14, 2015
Authorized Shares: 975,000,000 a/o Jun 30, 2015
Par Value: 0.001
$BSEM extra dd links
Company name: BioStem Technologies, Inc.
Company website: http://www.biostemtechnologies.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=BSEM+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=BSEM+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=BSEM+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/news - http://finance.yahoo.com/q/h?s=BSEM+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/BSEM/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=BSEM+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/BSEM
DTCC (dtcc.com): http://search2.dtcc.com/?q=BioStem+Technologies%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=BioStem+Technologies%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=BioStem+Technologies%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.biostemtechnologies.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.biostemtechnologies.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.biostemtechnologies.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/BSEM
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001634730&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=BSEM&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=BSEM
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=BSEM+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=BSEM+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=BSEM
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=BSEM
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=BSEM+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/BSEM/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=BSEM+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/BSEM.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=BSEM
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/BSEM/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/BSEM/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/BSEM
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/BSEM
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/BSEM:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=BSEM
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BSEM
$BSEM DD Notes ~ http://www.ddnotesmaker.com/BSEM
Don't worry.......................................you will see "VOLUME" soon enough.
JMHO
GLTA
7X10
This stock needs some volume.
First down day since large percentage increase last Friday. No news. Price seems to increase on any sort of buying activity. Very low volume. I wonder where this stock could go with any type of volume. My only guess is That there would be a very large price increase. No social media activity or nothing happening with this stock.
Well , at least it still held its ground today in spite of the fact that there is no news around . Sure hope there was some news so we can decide what to do with this company . It would be nice .
Any sort of increase in volume and this is going to rocket imo. Mm need to raise price to get people to sell so they can sell to buyers. The mms have none to sell imo.
Whats going on?
Big News is coming for BSEM $$$
Hope you comeback and check in down the road...
Thanx but no need........................you will be the one who needs them....................not me. But I wish you the best of luck.
GLTA
JMHO
7X10
I will send you a box of tissues in 6 months....lol
LOL......If it was not so sad it would be the funniest thing I have ever heard.
GLTA.........you will need it.
JMHO
7X10
It is a new company with new ownership that I think are doing some real nice things...there will be plenty of people here that will be quite happy as we move on down the road...make sure you check back in time to time...
RUN!!! Don't walk, RUN as fast as you can from this stock.
That is my advise to you. I was in this stock for 5 years, lost my a$$. Unfortunately recommended it to friends and family that also lost their a$$. Hundreds of thousands of dollars.
I finally sold what remaining stock I had after the two RS left me very little to sell. I used to have millions of shares. I sold my remaining 75 shares yesterday.Do your DD on this stock and you will run from it.
Hope this helps.
JMHO
GLTA
7X10
MY propos is :
Dear Machloje !!
make another split
1: 1000 000 000 for exemply
bravo rynek !
FOR WHAT INCOME ?? IF NOT GO UP !
How do they plan on generating revenue short term if their focus is strictly research?
Serious website had to cost 20-30k easy.
Company is up to far more than I thought!
Telomere
Stem Cells
Anti-aging
Didn't even know what telomeres were until watching the video!
Agreed, great site!
How about the videos?!
NEW WEBSITE!!!
Amazing and super informative! Learning a lot from the site.
I need advice from former traders here.
19.57$ is my target!!!!!
soooooon
I was told The new ticker symbol is sagn.
Stands for "Swanked again". LOL
GLTA
JMHO
7X10
This company was a Disco company, RS. Next was a gaming company, RS. Now stem cell, RS. At least pizza they could make money!
Ohhhh let me put on my Swankster surprised face.................
New crook in charge but still the same scammin ways as the ol coot Swanky.
Get some popcorn and watch the avalanche to come.
called company. Some guy answered said."Joes pizza"
ha ha ha ha ha :(
They have been asses the 7 or 8 years I've been with them! Next company will be a space travel and then a RS!
see what happens...had to clean it up
Followers
|
202
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
48320
|
Created
|
01/18/07
|
Type
|
Free
|
Moderators |
BioStem Technologies, Inc. Appoints David Wolfe and Dr. Michael Beckwith to Its Advisory Board
BioStem Technologies, Inc. Completes Capital Restructuring Initiatives
BioStem Technologies, Inc. Acquires TEN® Health Behavior Change Platform
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |